Literature DB >> 24256565

Impact of antioxidants on the ability of phenolic phytochemicals to kill HCT116 colon cancer cells.

A Murphy1, K Testa, J Berkelhammer, S Hopkins, G Loo.   

Abstract

Certain phenolic phytochemicals can kill cancer cells. Possible interference from antioxidants is a concern, and this issue has not been studied appreciably. Therefore, the effect of ascorbate and N-acetylcysteine on the ability of epigallocatechin gallate (EGCG) and curcumin to kill HCT116 colon cancer cells was examined. EGCG and curcumin each caused DNA damage in the cells. The DNA-damaging ability of EGCG, but not curcumin, was hindered by either ascorbate or NAC, which was also shown in HT29 and SW480 colon cancer cells. Also, iron chelators (deferoxamine and 2,2'-dipyridyl) inhibited the ability of EGCG, but not curcumin, to cause damage to the DNA in HCT116 cells. Interestingly, curcumin, but not EGCG, increased the expression of growth arrest and DNA damage-inducible gene 153 and also heme oxygenase-1, and this stress gene upregulation by curcumin was antioxidant-insensitive. With prolonged incubation of HCT116 cells with either EGCG or curcumin, cell shrinkage, membrane blebbing, apoptotic bodies, and chromatin condensation/fragmentation were observed. These morphological changes were not apparent in EGCG-treated cells that had been pretreated with either ascorbate or NAC. However, the ascorbate and NAC pretreatments did not prevent the occurrence of the morphological changes in curcumin-treated cells. Thus, these findings suggest that ascorbate and NAC interfere with the ability of EGCG, but not curcumin, to kill HCT116 cells. This basic knowledge may help to better plan and optimize strategies for chemoprevention or chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24256565     DOI: 10.3109/10715762.2013.867958

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  2 in total

Review 1.  Key factors which concur to the correct therapeutic evaluation of herbal products in free radical-induced diseases.

Authors:  Cesare Mancuso
Journal:  Front Pharmacol       Date:  2015-04-22       Impact factor: 5.810

Review 2.  Peroxiredoxins in Colorectal Cancer: Predictive Biomarkers of Radiation Response and Therapeutic Targets to Increase Radiation Sensitivity?

Authors:  Jesse Fischer; Tim W Eglinton; Frank A Frizelle; Mark B Hampton
Journal:  Antioxidants (Basel)       Date:  2018-10-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.